Search peptides, terms, sources/
Research source · 2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
1,961 adults with overweight/obesity, without diabetes
Sample size
1961
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Sponsor-funded (Novo Nordisk); 68-week duration.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.